Empery Asset Management
$86M 13F equity value
43 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Empery Asset Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| XFOR | X4 PHARMACEUTICALS INC | 6,930,591 | $32M | 37.4% |
| EMPD | EMPERY DIGITAL INC | 2,930,345 | $10M | 12.1% |
| NGEN | NERVGEN PHARMA CORP | 4,000,000 | $8M | 9.5% |
| DTIL | PRECISION BIOSCIENCES INC | 776,093 | $6M | 7.1% |
| CLNN | CLENE INC | 916,532 | $6M | 6.5% |
| ANVS | ANNOVIS BIO INC | 2,401,476 | $4M | 5.2% |
| LTRN | LANTERN PHARMA INC | 842,669 | $4M | 4.1% |
| AMC | AMC ENTMT HLDGS INC | 1,714,043 | $3M | 3.8% |
| TNYA | TENAYA THERAPEUTICS INC | 3,863,115 | $3M | 3.3% |
| YDDL | ONE AND ONE GREEN TECHNOLOGI | 761,706 | $2M | 1.8% |
Track Empery Asset Management's 13F portfolio: $86M in reported holdings, 43 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}